POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)
Part of paid clinical trials in Stanford, California.
- Sponsor
- Ethicon, Inc.
- Study ID
- NCT05299606
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transbronchial Microwave Ablation — DEVICETransbronchial microwave ablation will be performed using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone.
Study Details
This is a prospective, multicenter, single-arm study on transbronchial microwave ablation using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone. The primary endpoint is Technique Efficacy, assessed 30-days post-ablation via CT imaging.
Key Dates
- Start date
- Oct 21, 2022
- Status verified
- Nov 2025
- Primary completion
- Oct 18, 2024
- Completion
- Oct 18, 2024
Study Design
- Enrollment
- 12 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Transbronchial Microwave AblationTransbronchial microwave ablation will be performed using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone.
Primary Outcome Measure
Number of Patients Whose Ablation Resulted in Technique Efficacy [ Time Frame: 30 days post-ablation ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | - |
| UCONN Health | Farmington | Connecticut | 06030 | - |
| Minnesota Lung Center | Minneapolis | Minnesota | 55407 | - |
| FirstHealth Moore Regional Hospital | Pinehurst | North Carolina | 28374 | - |
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| MD Anderson | Houston | Texas | 77030 | - |
Find similar trials in Stanford, CA
By condition
By specialty
Related Studies
- Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54Recruiting · Wake Forest University Health Sciences · Charlotte, North Carolina
- TELESCOPE- TELEhealth Shared Decision-making COachingRecruiting · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerPHASE2 · Recruiting · Pfizer · Duarte, California
- Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung CancerRecruiting · University of Colorado, Denver · Aurora, Colorado